[Federal Register Volume 67, Number 155 (Monday, August 12, 2002)]
[Notices]
[Pages 52493-52494]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-20271]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Act, as amended 
(5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which

[[Page 52494]]

would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel, COX2 Inhibitors in 
Proteinuric Renal Insufficiency.
    Date: August 29, 2002.
    Time: 2 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: 2 Democracy Plaza, 6707 Democracy Blvd., Room 750, 
Bethesda, MD 20892. (Telephone Conference Call).
    Contact Person: Neal A. Musto, PhD, Scientific Review 
Administrator, Review Branch, DEA, NIDDK, Room 750, 6707 Democracy 
Boulevard, National Institutes of Health, Bethesda, MD 20892-6600. 
(301) 594-7798. [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hermatology Research, National Institutes of Health, HHS)

    Dated: August 5, 2002
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-20271 Filed 8-9-02; 8:45 am]
BILLING CODE 4140-01-M